Lv21
180 积分 2024-02-20 加入
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
1小时前
已完结
CAR T-cell therapy in autoimmune diseases
4个月前
已完结
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
4个月前
已完结
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children
6个月前
已完结
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
6个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
8个月前
已完结
An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases
10个月前
已完结
Development of Novel Glucocorticoids for Use in Antibody–Drug Conjugates for the Treatment of Inflammatory Diseases
10个月前
已完结
Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody–Drug Conjugate Payloads
10个月前
已完结
Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells
10个月前
已完结
皖公网安备34019202002308
